Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future

Osteosarcoma (OS), the most common malignant tumor in the musculoskeletal system, mainly occurs in adolescents. OS results in high mortality and disability rates due to a fatal metastatic tendency and subsequent iatrogenic damage caused by surgery, radiotherapy and chemotherapy. Recently, immunother...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zeng, Tan, Xin, Jiang, Zengxin, Wang, Hao, Yuan, Hengfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618820/
https://www.ncbi.nlm.nih.gov/pubmed/36324681
http://dx.doi.org/10.3389/fphar.2022.1031527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618820/
https://www.ncbi.nlm.nih.gov/pubmed/36324681
http://dx.doi.org/10.3389/fphar.2022.1031527

Ejemplares similares